News and Trends 13 Dec 2016 European Pharma closes 2016 by launching new Biotech Startups Big pharma is already head on starting 2017 with a bang. Pfizer and Bayer are launching US-based startups in oncolytic virus and stem cell therapies. Pharma is wrapping up 2016… December 13, 2016 - 2 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 30 Mar 2022 BIO-Europe Spring 2022: The Highlights …(SMEs); and widening Europe’s local focus to benefit patients worldwide. Public-private partnerships and conditional regulatory approvals played a key role in accelerating the development of the first Covid-19 vaccines in… March 30, 2022 - 13 minutesmins - By Editorial Team Share WhatsApp Twitter Linkedin Email
In Depth 12 Jul 2023 Medicon Valley: how the initiative shaped biotech ecosystems in Denmark and Sweden …that can produce and develop new vaccines, then, we are in trouble. So the political interests of the sector became even greater,” said Hartman. This has led to the emergence… July 12, 2023 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 6 Sep 2022 Lonza and Touchlight collaboration will expands customer’s access to DNA …mRNA-based therapeutics in development include vaccines for infectious diseases and immuno-oncology. Karen Fallen, CEO, Touchlight DNA services, added: “We are delighted to provide Touchlight customers the benefits of an end-to-end… September 6, 2022 - 2 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 5 Apr 2023 InflaRx receives emergency use authorization for critically ill COVID-19 patients treatment …sick patient group, recognizing the lifesaving potential of this first-in-class drug. Despite the availability of vaccines and other treatments for earlier disease stages of COVID-19, many patients are still developing… April 5, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Expert Advice 12 Sep 2025 Eight biotech career paths where demand is skyrocketing …on disease-causing microbes and use the information they find to develop vaccines and improve current treatments. As Penrose commented, microbiologists’ “ability to pioneer microbiome-focused diagnostic tools and personalized medical treatments… September 12, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 12 May 2023 Achilles Therapeutics’ new platform identifies most potent T-cell antigens …modalities including clonal neoantigen cancer vaccines. Personalized neoantigen approaches “We believe our “Target-to-T Cell” approach will be fundamental to unlocking the potential of precision therapies from our own T cell… May 12, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 24 Jun 2025 Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem …their local ecosystems. For example, Lyon excels in vaccines and pharmaceutical production, Strasbourg in personalized medicine, Nantes in biotherapies and tissue regeneration, and Toulouse in oncology and bioprocessing. Île-de-France, however,… June 24, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 24 Mar 2017 Novartis puts the Development of two Anti-Aging Drugs in American Hands …of cancer. Preclinical research seemed to indicate that this drug could also extend the lifespan and boost the efficacy of vaccines, which led the company to start human trials. However,… March 24, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 22 Nov 2022 Achilles Therapeutics receives US patent for immunotherapies …has potential different modalities including vaccines, antibodies and autologous T cell therapies.” The patented technology is based on a statistical framework to determine the probability that a mutation is clonal… November 22, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 26 Sep 2025 Can biotechnology reduce animal testing in medicine? …the COVID-19 pandemic, researchers used in silico models to investigate how various vaccines fought the virus, and the results were remarkably consistent with those from human trials. With the recent… September 26, 2025 - 14 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email